Abstract
Background: It remains unknown whether patients with severe decompensated class IV heart failure (HF) receiving intravenous inotropic treatment benefit from cardiac resynchronization therapy (CRT). Methods: We identified patients who underwent urgent CRT implantation due to decompensated class IV HF necessitating intravenous inotropic therapy. Results: Of 10 patients with chronic ischemic cardiomyopathy (median QRS duration of 170 ms), CRT implantation was associated with symptomatic improvement in 8 patients. The mortality rate was 50% during a median follow-up of 9.5 months, with a median CRT-to-death duration of 6 months. Conclusions: CRT was feasible among class IV patients receiving inotropic treatment and was associated with clinical improvement.
| Original language | English |
|---|---|
| Pages (from-to) | 59-62 |
| Number of pages | 4 |
| Journal | Cardiology |
| Volume | 106 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1 Jun 2006 |
| Externally published | Yes |
Keywords
- Cardiac resynchronization therapy
- Death
- Heart failure
- Inotropic treatment
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Pharmacology (medical)